Chemours, Tronox And Westlake Will See Earnings Rebound In Chemical Sector Amid TiO2 Recovery And Margin Expansion: Analyst
1. Analyst initiated Buy rating on Chemours with a $27 price target. 2. Expecting strong earnings growth in 2025-2026 for Chemours. 3. Opteon refrigerant margins and TiO2 rebound seen as positive factors. 4. Forecasted EBITDA growth suggests upside from current consensus estimates. 5. New management strategies may enhance valuations and margins.